Prestige Brands Buys Care Pharmaceuticals of Australia

Prestige Brands (NYSE: PBH  ) is reaching to the other side of the world for its latest acquisition. The company announced that it has purchased the privately held Care Pharmaceuticals, based in New South Wales, Australia. The terms of the deal were not disclosed, although Prestige Brands did admit that it would be funded by monies drawn from an existing credit facility combined with cash on hand.

Care Pharmaceuticals produces a number of over-the-counter treatments, most notably the Fess line of nasal-health products, which includes what Prestige Brands says is the No. 1 saline spray on the local market. Many of Care Pharmaceuticals' goods are intended for infants or children.

The Australian company was formed in 1986. Its new owner said its annual revenues are roughly $20 million in Australian dollars ($18.2 million).


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2529101, ~/Articles/ArticleHandler.aspx, 10/30/2014 1:00:56 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement